Profile picture

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)
Membership: ESC Professional Member HFA Member
Follow
Biography
Pr Thibaud Damy’s field of interest are Heart failure and Cardiac Amyloidosis, through to their diagnosis and treatment. His particular current interests are developpement of HF Nurses in France and improving CA diagnosing and treatment at the national level. He is working at the Hospital Henri Mondor, at Paris East Creteil University (UPEC) and at INSERM U955 (Clinical EPidemiology in Aging (CEPIA). He is leading the Referral Center for Cardiac Amyloidosis from the Cardiogen French Network /ERN. He and his team created a wide educational programme to improve the knowledge and quality of life of the patients (Amylo-PEP). He is leading the French National Amyloidosis Network gathering and the Healthcare European Amyloidosis Registry that has included around 4500 patients with amyloidoisis. He is a co-author of around 240 articles (>100 on amyloidosis). He is coordinating several websites : www.reseau-amylose.org, www.vaincrelinsuffisancecardiaque.org
Logo ESC

Contributor content

Transthyretin amyloidosis: long-term outcomes and emerging therapies
Session
Transthyretin amyloidosis: long-term outcomes and emerging therapies
11 May 2026
Myosin inhibition in hypertrophic cardiomyopathy: beyond the classic left ventricular outflow tract story
Session
Myosin inhibition in hypertrophic cardiomyopathy: beyond the classic left ventricular outflow tract story
11 May 2026
Myocardial disease - clinical 3
Session
Myocardial disease - clinical 3
13 May 2024
How to manage cardiac amyloidosis
Session
How to manage cardiac amyloidosis
13 May 2024
Evaluation of prognosis in cardiomyopathies
Session
Evaluation of prognosis in cardiomyopathies
12 May 2024
Challenges in ATTR Amyloidosis: an expert debate
Session
Challenges in ATTR Amyloidosis: an expert debate
11 May 2024
Ask the Trialists from Hot Line 5
Session
Ask the Trialists from Hot Line 5
27 August 2023
Chronic heart failure - Amyloidosis
Session
Chronic heart failure - Amyloidosis
27 August 2022
Myocardial disease: clinical characterization and therapeutical progress
Session
Myocardial disease: clinical characterization and therapeutical progress
23 May 2022
New targets to enhance survival and outcomes in hATTR amyloidosis
Session
New targets to enhance survival and outcomes in hATTR amyloidosis
22 May 2022

ESC 365 is supported by